1-4 of 4
Natalie Nguyen
Close
Sort by
Journal Articles

A Phase Ib/II Study of Ibrutinib in Combination with Obinutuzumab-Gazyva As First-Line Treatment for Patients with Chronic Lymphocytic Leukemia > 65 Years Old or with Coexisting Conditions

Carlos I. Amaya-Chanaga, MD, Michael Y. Choi, MD, Natalie Nguyen, B.Sc, Elizabeth DeVore, B.Sc, Colin MacCarthy, B.Sc, Jacqueline Hilger-Rolfe, PhD, M.S., Thomas J. Kipps, MD, PhD, Januario E. Castro, MD
Journal: Blood
Blood (2016) 128 (22): 2048.
https://doi.org/10.1182/blood.V128.22.2048.2048
Published: 2016
Journal Articles

A Phase Ib/II Study of Combined Obinutuzumab (Gazyva) and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, MD, Michael Y. Choi, MD, Carlos I. Amaya-Chanaga, MD, Natalie Nguyen, B.Sc, Colin MacCarthy, B.Sc, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 2051.
https://doi.org/10.1182/blood.V128.22.2051.2051
Published: 2016
Journal Articles

A Phase Ib/II Study of Combined Obinutuzumab and High-Dose Methylprednisolone (HDMP) As Treatment for Patients with Chronic Lymphocytic Leukemia (CLL)

Januario E. Castro, MD, Michael Y. Choi, MD, Carlos I. Amaya-Chanaga, MD, Natalie Nguyen, B.Sc, Amine Ale-Ali, PharmD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 4160.
https://doi.org/10.1182/blood.V126.23.4160.4160
Published: 2015
Journal Articles

A Liposomal Formulation of KRN7000 (RGI-2001) Potently Reduces GvHD Lethality through the Expansion of CD4 + Foxp3 + Regulatory T Cells in Murine Models

Omar Duramad, PhD, Amy Laysang, Jun Li, Natalie Nguyen, Yasuyuki Ishii, PhD, Reiko Namikawa, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3500.
https://doi.org/10.1182/blood.V112.11.3500.3500
Published: 2008